Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease.
Mennetrey C, Le Bras M, Bando-Delaunay A, Al-Mansour L, Haissaguerre M, Batisse-Lignier M, Ouvrard E, Ansquer C, Walter T, de Mestier L, Kelly A, Tlili G, Giraud S, North MO, Odou MF, Goichot B, Cuny T, Loundou A, Romanet P, Imperiale A, Taïeb D. Mennetrey C, et al. Among authors: al mansour l. J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2056-e2064. doi: 10.1210/clinem/dgab891. J Clin Endocrinol Metab. 2022. PMID: 34940846
Identification of lipomatous metaplasia on computed tomography images helps confirm prior silent myocardial infarction associated with equivocal perfusion abnormality on single-photon emission computed tomography/computed tomography imaging.
Dietz M, Bochaton T, Al Mansour L, Tordo J, Flaus A. Dietz M, et al. Among authors: al mansour l. J Nucl Cardiol. 2024 Feb;32:101812. doi: 10.1016/j.nuclcard.2024.101812. Epub 2024 Jan 20. J Nucl Cardiol. 2024. PMID: 38246257 No abstract available.
Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network.
Al Mansour L, De Mestier L, Haissaguerre M, Afchain P, Hadoux J, Lecomte T, Morland D, Cottereau AS, De Rycke O, Tlili G, Tordo J, Janier M, Deville A, Walter T. Al Mansour L, et al. J Nucl Med. 2024 Feb 1;65(2):258-263. doi: 10.2967/jnumed.123.266063. J Nucl Med. 2024. PMID: 38212066